PROCEPT BioRobotics (PRCT) Change in Cash (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Change in Cash data on file, last reported at -$40.9 million in Q1 2026.

• On a quarterly basis, Change in Cash fell 133.25% year-over-year to -$40.9 million in Q1 2026; TTM through Mar 2026 was -$70.6 million, a 177.86% decrease from a year earlier, with the FY2025 full-year figure at -$47.2 million, down 161.73% from the prior year.
• Change in Cash for Q1 2026 stood at -$40.9 million, down from -$7.8 million in the prior quarter.
• Over the last five years, Change in Cash for PRCT reached as high as $137.4 million in Q3 2023 and fell as low as -$40.9 million in Q1 2023.
• Historically, Change in Cash has averaged -$3.3 million across 5 years, with a median of -$17.3 million in 2024.
• On a YoY basis, Change in Cash climbed as much as 767.36% in 2023 and fell as far as 140.58% in 2023.
• Year by year, Change in Cash stood at -$27.4 million in 2022, then declined by 12.0% to -$30.6 million in 2023, then surged by 546.98% to $137.0 million in 2024, then sank by 105.68% to -$7.8 million in 2025, then slumped by 425.34% to -$40.9 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$40.9 million in Q1 2026, -$7.8 million in Q4 2025, and -$8.4 million in Q3 2025.